Therapeutics has filed a Form 8-K with the U.S. Securities and Exchange Commission, SEC, regarding its agreement in principle ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

Applied DNA Sciences Inc. (NASDAQ: APDN) submitted a Form 8-K filing on January 24, 2025, reporting changes in its certifying accountant. The company noted that on November 1, 2024, CBIZ CPAs P.C.

National Bank Holdings Corporation (NYSE: NBHC) submitted a current report on Form 8-K to the Securities and Exchange Commission (SEC) on January 29, 2025. This filing discloses the company’s ...

Allarity remains financially positioned to continue its core operations, including the ongoing development of stenoparib, as planned into 2026. The full Form 8-K filing is available on the SEC’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The annual reporting season for calendar year-end companies is in full swing and public companies should consider several new ...

Waste Management (NYSE: WM) Q4 2024 Earnings Call Jan 30, 2025, 10:00 a.m. ET Good day. Thank you for standing by. Welcome to ...

This Client Alert provides an overview of new developments and highlights key considerations for calendar year-end public ...